US federal court orders Philips Respironics to halt production of sleep apnea machines, address safety issues, and complete a global recall of 5 million machines with toxic foam.

Philips Respironics has been ordered by a US federal court to halt production of sleep apnea machines at three facilities until it meets specific safety requirements. The company, involved in a global recall of sleep apnea machines since 2021, must overhaul its manufacturing and quality control systems, hire independent experts to vet the changes, and continue to replace, repair or provide refunds to US customers. The recall involves over 5 million machines with internal foam that can break down over time, leading to inhalation of toxic particles and fumes.

April 09, 2024
16 Articles

Further Reading